Neuren Pharmaceuticals | NEU - Cash And Equivalent


Neuren Pharmaceuticals reported AUD4.23M in Cash and Equivalent for its fiscal semester ending in December of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 155.55M 7.1M Jun/2026
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Avita Medical AUD 10.24M 1.98M Dec/2025
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Dianthus Therapeutics USD 110.55M 517.12M Jun/2026
Genetic Signatures AUD 7.47M 33.32M Jun/2025
Ionis Pharmaceuticals USD 350.06M 1.57B Jun/2026
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Organon & Co USD 1.13B 16M Jun/2026
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Tectonic Therapeutic USD 236.89M 16.9M Mar/2026
Telix Pharmaceuticals AUD 141.87M 65.29M Dec/2025
Viatris USD 886.5M 917.7M Jun/2026
Xeris Pharmaceuticals USD 121.75M 10M Jun/2026